CD274 and cancer: We found no difference in the immune dysfunction, microsatellite instability (MSI), myeloid-derived suppressor cells (MDSC), and cancer-associated fibroblasts (CAF) scores, or in mRNA levels of CD274 (PD-L1) and CD8 (Supplementary Fig. 8B–G).